Transcend Medical, Inc.: Series B $16M

Posted in I - Series B, Q - 3Q11, R - WEST, X - Device (Ophthalmology), XX - CA

Transcend Medical (Menlo Park, CA) a clinical-stage medical device company focused on the treatment of glaucoma, closed a $16 Series B, bringing the total round to $51M. Participants include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners.
Thanx for your [...]

Oct

2011

Valeritas, Inc.: Series C $150M

Posted in I - Series C, Q - 3Q11, R - NORTH EAST, X - Device (Delivery), X - Device (Diabetes), XX - NJ

Valeritas (Bridgewater, NJ) a commercial-stage developer of a disposable insulin delivery device, closed a $150M Series C financing. Participants include Welsh, Carson, Anderson & Stowe, MPM Capital, Pitango Venture Capital, Abingworth Management, Advanced Technology Ventures, Onset Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures.

Jul

2010

Agile Therapeutics, Inc.: Series B $45M

Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Contraception, X - Drug:Device Combo, XX - NJ

Agile Therapeutics (Princeton, NJ) a clinical-stage pharmaceutical company focused on hormonal contraception, closed a $45M Series B financing. Participants include Investor Growth Capital, Care Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

Jun

2010

Baxano, Inc.: Series C $30M

Posted in I - Series C, Q - 2Q10, R - WEST, X - Device (Spine), XX - CA

Boxano (Mountain View, CA) a commercial-stage medical device company focused on lumbar spinal stenosis, closed a $30M Series C financing. Participants include CMEA Capital, Kaiser Permanente Ventures, Affinity Capital Management, Prospect Venture Partners, Three Arch Partners and Kearny Venture Partners.

Jun

2010

Predictive Biosciences, Inc.: Series C $25M

Posted in I - Series C, Q - 2Q10, R - NORTH EAST, X - Device (Diagnostic), X - Oncology, XX - MA

Predictive Biosciences (Lexington, MA) a commercial-stage molecular diagnostic company focused on oncology assays, closed a $25M Series C financing. Participants ProQuest Investments, Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.

May

2010

Oxford Immunotec, Ltd.: Series D $26M

Posted in I - Series D, Q - 2Q10, R - INTERNATIONAL, X - Device (Diagnostic), X - Tuberculosis

Oxford Immunotec (United Kingdom) a commercial-stage molecular diagnostic company focused on an vitro test for the diagnosis of active and latent tuberculosis infection, closed a $26M Series D financing. Participants include New Leaf Venture Partners, Kaiser Permanente Ventures, Clarus Ventures, Wellington Partners, National Technology Enterprises Company, Spark Ventures, DFJ Esprit, Oxford University and Dow Chemical.

Apr

2010

Hemosphere, Inc.: Series A $9.3M

Posted in I - Series A, Q - 1Q10, R - MID WEST, X - Device (Dialysis), XX - MN

Hemosphere (Eden Prairie, MN) a commercial-stage medical device company focused on vascular access for dialysis patients, closed a $9.3M Series A financing, bringing the total round to $36.3M (GRAFTcath). Participants have included Kaiser Permanente Ventures, Three Arch Partners, Ascension Health Ventures, Affinity Capital Management, Cutlass Capital and Sapient Capital Management.

Jan

2010

Accumetrics, Inc.: Series E $16.6M

Posted in I - Series E, Q - 4Q09, R - WEST, X - Device (Diagnostic), XX - CA

Accumetircs (San Diego,CA) a commercial-stage diagnostic company focused on VerifyNow® System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies, closed a $16.5M Series E financing. Participants inlcude Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming [...]

to top of page...